Project Grant HT94252510419
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$1.9M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
The Cleveland Clinic Foundation received a $799,998 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to support research strategies for enhancing spinal plasticity and promoting recovery from spinal cord injury. The award term runs from September 15, 2025 to September 14, 2028. The Military Medical Research and Development program funds advanced biomedical research initiatives focused on transforming healthcare for military...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $650,138 Project Grant to The Cleveland Clinic Foundation on September 1, 2024. The grant will fund a 2-year study focused on developing biomarkers to assess patient response to neurorestorative therapies for cervical spinal cord injuries. The Cleveland Clinic Foundation, a non-profit academic medical center, will leverage its expertise in neuroscience research to advance this...
The Department of Defense's Defense Health Agency awarded The Cleveland Clinic Foundation a $383,740 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the research and development of a "Novel Graft-Localized Drug Delivery Platform for Attenuating Innate Inflammation and Optimizing Immunosuppression in Vascularized Composite Allotransplantation." This project aims to develop innovative medical...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $999,999 Project Grant to The Cleveland Clinic Foundation to conduct research on "Inhibiting Demyelination Rescues Synapse Loss in Multiple Sclerosis." The grant period runs from June 1, 2024 to May 31, 2027. The Cleveland Clinic Foundation, a non-profit academic medical center, will use the funding to carry out innovative biomedical research aimed at developing new treatments...
The Defense Health Agency awarded a $1,139,124 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development program (CFDA 12.420) to investigate the "Novel Nuclear Localization of the Complement Regulator CD55 Identifies a New Hook for Disrupting Ovarian Cancer Progression." This 4-year grant, with a period of performance from May 1, 2025 to April 30, 2029, will support advanced medical research focused on developing innovative solutions to...
The Defense Health Agency awarded The Cleveland Clinic Foundation, a non-profit academic medical center, a $893,768 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The two-year grant, effective from September 1, 2023 to August 31, 2025, supports the development of multimodal AI-based solutions to enhance renal cancer patient care. As a leader in medical research, education, and healthcare delivery, The Cleveland Clinic Foundation will leverage its...
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $2,602,024 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2024, will fund research on the "Role of Stress in the Degradation of Intestinal IgA and Intestinal Health" over a 4-year period ending on September 29, 2028. As a prominent academic medical center, The Cleveland Clinic Foundation...
The Cleveland Clinic Foundation was awarded a $712,508 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2022 through August 31, 2025. The grant aims to assess the role of glycated apolipoprotein A1 (apoA1) in relation to cognitive complications of diabetes and preclinical Alzheimer's disease. As the primary awardee, Cleveland Clinic will analyze glycated apoA1 levels in plasma samples from...
The Cleveland Clinic Foundation will receive $785,000 through a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research on engineered carbon nanomaterials for the prevention of UV-induced melanomagenesis. Through September 2025, the Cleveland Clinic Foundation will investigate medical solutions to develop nanomaterials that can protect against skin cancer caused by ultraviolet...